VRAY News and Press, ViewRay Inc. From 01/23/23

ViewRay ( NASDAQ: VRAY ) has reached an agreement with Hudson Executive Capital to appoint Sai Nanduri, senior investment analyst and representative of HEC, as an observer of the ViewRay Board of Directors, effective as of January 20, 2023. The company Board will appoint ...

Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer PR Newswire MIRAGE phase III randomized controlled trial shows a significant reduction in GU and GI toxicities with ...

ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer PR Newswire DENVER , Jan. 9, 2023 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financi...

ViewRay ( NASDAQ: VRAY ) shares surged ~15% to the highest level in nearly a year on Thursday after the medical equipment maker announced new orders for its MRIdian MRI-guided radiation therapy system. MRIdian is designed to provide oncologists with diagnostic-quality magnetic res...

Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment PR Newswire Purchase agreement with ViewRay will make state-of-the art precision radiation therapy available in China DENVER , Jan. 5, 2023 /PRNewswire/ -- ViewRay...

University Hospitals in Cleveland Enters into Master Purchase Agreement with ViewRay for Multiple MRIdian® Systems PR Newswire Immediate order of one system with ability to purchase an additional three systems DENVER , Jan. 5, 2023 /PRNewswire/ -- Vi...

ViewRay ( NASDAQ: VRAY ) announced a five-year loan facility deal with MidCap Financial ( MFIC ) and Silicon Valley Bank, consisting of a $100M term loan and a $25M revolving line of credit. The term loan commitment is up to $100M, $25M of which ViewRay ( V...

ViewRay Expands Access to Non-Dilutive Capital With New Debt Facility PR Newswire Facility includes senior secured term loan of up to $100 million and a revolving line of credit of up to $25 million DENVER , Nov. 14, 2022 /PRNewswire/ -- V...

ViewRay® to Participate in the 34th Annual Piper Sandler Healthcare Conference PR Newswire DENVER , Nov. 14, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the 34th Annual Piper Sandler Healthcare C...

ViewRay® to Present at the Stifel 2022 Healthcare Conference PR Newswire DENVER , Nov. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Stifel 2022 Healthcare Conference. Scott Drake , Pre...